ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,801, issued on Oct. 14, was assigned to JANSSEN PHARMACEUTICA NV (Beerse, Belgium).
"Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying same" was invented by Linda A. Snyder (Pottstown, Pa.), Gordon Powers (Malvern, Pa.), Enrique Zudaire Ubani (Ambler, Pa.) and Douglas Matthew Marvel (Lansdale, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain biological responses using the antibodies. Compositions and methods of using anti-VISTA antibodies in combination with one o...